Position in XNCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$868,112
-$43,382 QoQ
Shares Held
53,920
-28.7% QoQ
Ownership
0.073%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 208 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XNCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. XNCR ranks #96 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in XNCR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $868,112 | 53,920 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $911,494 | 75,580 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,496,537 | 97,749 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $819,645 | 69,876 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $712,108 | 90,599 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $922,924 | 86,741 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,194,408 | 51,976 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,292,530 | 64,273 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,808,098 | 95,515 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,075,980 | 229,371 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,543,736 | 119,818 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,230,343 | 110,687 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,969,407 | 118,919 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,541,695 | 126,988 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,035,248 | 116,561 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,970,605 | 114,342 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,889,050 | 69,019 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,499,889 | 93,699 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,599,535 | 64,794 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,480,085 | 45,318 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,659,244 | 48,108 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,597,637 | 60,326 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $517,320 | 11,857 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,048,028 | 27,018 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $630,503 | 19,466 | Shares | Sole | 2020-08-07 | |
| No filing history on record for this holder in this stock. | ||||||